278 related articles for article (PubMed ID: 26003033)
21. Serum tryptase measured with B12 and G5 antibody-based immunoassays in mastocytosis patients and its relation to histamine turnover.
Granerus G; Lönnqvist B; Nystrand J; Roupe G
Br J Dermatol; 1998 Nov; 139(5):858-61. PubMed ID: 9892955
[TBL] [Abstract][Full Text] [Related]
22. An update on mast cell disorders.
Cookson H; Grattan C
Clin Med (Lond); 2016 Dec; 16(6):580-583. PubMed ID: 27927825
[TBL] [Abstract][Full Text] [Related]
23. Dental management of a patient with systemic mastocytosis.
Legge AR; Whyte A; Heywood S
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35428668
[TBL] [Abstract][Full Text] [Related]
24. Mastocytosis in infants and children: recognition of patterns of skin disease.
Kirshenbaum AS; Kettelhut BV; Metcalfe DD; Garriga MM
Allergy Proc; 1989; 10(1):17-21. PubMed ID: 2925086
[TBL] [Abstract][Full Text] [Related]
25. Aggressive systemic mastocytosis.
Inaoui R; Petit B; Jaccard A; Bertin P; Trèves R
Joint Bone Spine; 2003 Feb; 70(1):64-6. PubMed ID: 12639621
[TBL] [Abstract][Full Text] [Related]
26. Cladribine therapy for systemic mastocytosis.
Kluin-Nelemans HC; Oldhoff JM; Van Doormaal JJ; Van 't Wout JW; Verhoef G; Gerrits WB; van Dobbenburgh OA; Pasmans SG; Fijnheer R
Blood; 2003 Dec; 102(13):4270-6. PubMed ID: 12933573
[TBL] [Abstract][Full Text] [Related]
27. Bone marrow involvement in cutaneous mastocytosis.
Fearfield LA; Francis N; Henry K; Costello C; Bunker CB
Br J Dermatol; 2001 Mar; 144(3):561-6. PubMed ID: 11260015
[TBL] [Abstract][Full Text] [Related]
28. No indication of aberrant neutrophil extracellular trap release in indolent or advanced systemic mastocytosis.
Rosell A; Karlström C; Dahlin JS; Boey D; Klimkowska M; Ax K; Thålin C; Ungerstedt J
Scand J Immunol; 2024 Jan; 99(1):e13333. PubMed ID: 38112220
[TBL] [Abstract][Full Text] [Related]
29. Small bowel obstruction: a rare presentation of systemic mastocytosis.
Babu B; Subbiah Nagaraj S; Gopalam V; Vaiphei K
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37751976
[TBL] [Abstract][Full Text] [Related]
30. Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients.
Kettelhut BV; Parker RI; Travis WD; Metcalfe DD
Am J Clin Pathol; 1989 May; 91(5):558-62. PubMed ID: 2470248
[TBL] [Abstract][Full Text] [Related]
31. Intestinal mucosal mast cells: enumeration in urticaria pigmentosa and systemic mastocytosis.
Ferguson J; Thompson RP; Greaves MW
Br J Dermatol; 1988 Nov; 119(5):573-8. PubMed ID: 3207611
[TBL] [Abstract][Full Text] [Related]
32. Electron microscopic findings in a case of systemic mastocytosis.
Sauer O; Nemetschek
Z Kinderheilkd; 1975; 119(1):59-69. PubMed ID: 1124588
[TBL] [Abstract][Full Text] [Related]
33. Urticaria pigmentosa and systemic mastocytosis.
Keow J; Chin-Yee B; Hsia CC; Robertson K
Clin Case Rep; 2023 Dec; 11(12):e8302. PubMed ID: 38111510
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of mastocytosis: value of cytochemistry and immunohistochemistry.
Li CY
Leuk Res; 2001 Jul; 25(7):537-41. PubMed ID: 11377678
[TBL] [Abstract][Full Text] [Related]
35. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
Lübke J; Schmid A; Christen D; Oude Elberink HNG; Span LFR; Niedoszytko M; Gorska A; Lange M; Gleixner KV; Hadzijusufovic E; Stefan A; Angelova-Fischer I; Zanotti R; Bonifacio M; Bonadonna P; Shoumariyeh K; von Bubnoff N; Müller S; Perkins C; Elena C; Malcovati L; Hagglund H; Mattsson M; Parente R; Varkonyi J; Fortina AB; Caroppo F; Brockow K; Zink A; Breynaert C; Leven T; Yavuz AS; Doubek M; Sabato V; Schug T; Hartmann K; Triggiani M; Gotlib J; Hermine O; Arock M; Kluin-Nelemans HC; Panse J; Sperr WR; Valent P; Reiter A; Schwaab J
Blood Adv; 2024 Jun; 8(11):2890-2900. PubMed ID: 38593217
[TBL] [Abstract][Full Text] [Related]
36. Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis.
Pehlivanidis C; Fotoulaki M; Boucher W; Kempuraj D; Pang X; Konstantinidou A; Theoharides TC
J Clin Psychopharmacol; 2002 Apr; 22(2):221-4. PubMed ID: 11910271
[No Abstract] [Full Text] [Related]
37. [Bone involvement with osteolytic predominance in systemic mastocytosis. A clinical case].
Buchon R; Schoenenberger P; Vicens JL; Flageat J
J Radiol; 1992; 73(8-9):443-9. PubMed ID: 1474520
[TBL] [Abstract][Full Text] [Related]
38. Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients.
Casassus P; Caillat-Vigneron N; Martin A; Simon J; Gallais V; Beaudry P; Eclache V; Laroche L; Lortholary P; Raphaël M; Guillevin L; Lortholary O
Br J Haematol; 2002 Dec; 119(4):1090-7. PubMed ID: 12472593
[TBL] [Abstract][Full Text] [Related]
39. Treatment of mastocytosis: pharmacologic basis and current concepts.
Marone G; Spadaro G; Granata F; Triggiani M
Leuk Res; 2001 Jul; 25(7):583-94. PubMed ID: 11377684
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology.
Brockow K; Akin C; Huber M; Metcalfe DD
J Am Acad Dermatol; 2003 Apr; 48(4):508-16. PubMed ID: 12664011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
